Пошук


Поточні фільтри:


Почати новий пошук
Додати фільтри:

Використовуйте фільтри для уточнення результатів пошуку.


Результати 1-9 зі 9.
  • назад
  • 1
  • далі
Знайдені матеріали:
Дата випускуНазваАвтор(и)
2021A potential role of fecal oxalate-degrading activity in oxalate homeostasis in end-stage renal disease patients; a descriptive pilot studyStepanova, N.; Tolstanova, G.; Korol, L.; Akulenko, I.; Savchenko, O.; Kolesnyk, M.
2021Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot studyStepanova, N.; Driianska, V.; Korol, L.; Snisar, L.; Lebed, L.
2021Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion ArticleStepanova, N.
2021Hyperoxaluria; a risk factor or a consequence of recurrent pyelonephritis?Stepanova, N.
2021Hyperuricemia Predicts Residual Diuresis Decline in Peritoneal Dialysis PatientsStepanova, N.; Snisar, L.; Lebid, L.
2021The long-term effects of acute kidney injury on intestinal oxalate-degrading bacteria in rats. Nephrol Dial TransplantStepanova, N.; Tolstanova, G.; Nepomnyashchii, V.; Akulenko, I.; Savchenko, S.; Kolesnyk, M.
2021The association between nephrotic-range proteinuria and oxalate metabolism violation in patients with primary glomerulonephritisStepanova, N.; Snisar, L.; Lebid, L.; Savchenko, S.
2021Could the residual renal function remain a key determinant of plasma oxalic acid concentration in peritoneal dialysis patients?Stepanova, N.; Korol, L.; Snisar, L.; Lebid, L.
2021Plasma oxalic acid as a significant risk factor for cardiovascular disease in end-stage renal disease patientsStepanova, N.; Snaisar, L.; Lebid, L.